Interferon beta-1a
Avonex, Rebif (interferon beta-1a) is a protein pharmaceutical. Interferon beta-1a was first approved as Avonex on 1996-05-17. It is used to treat multiple sclerosis in the USA. It has been approved in Europe to treat multiple sclerosis.
| Trade Name | Avonex, Rebif |
|---|---|
| Common Name | Interferon beta-1a |
| Indication | multiple sclerosis |
| Drug Class |
